These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 28069527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver Transplantation.
    Kim J, Kim YT, Lee JG, Han DH, Joo DJ, Kim DY, Seong J.
    Int J Radiat Oncol Biol Phys; 2024 Jul 15; 119(4):1171-1178. PubMed ID: 38364951
    [Abstract] [Full Text] [Related]

  • 3. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ, Rochon PJ, Chang S, Ray CE, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J.
    J Vasc Interv Radiol; 2013 Nov 15; 24(11):1613-22. PubMed ID: 24060436
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY, Ou HY, Huang TL, Chen TY, Tsang LL, Chen CL, Cheng YF.
    Transplant Proc; 2012 Mar 15; 44(2):412-4. PubMed ID: 22410030
    [Abstract] [Full Text] [Related]

  • 6. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
    Barakat O, Wood RP, Ozaki CF, Ankoma-Sey V, Galati J, Skolkin M, Toombs B, Round M, Moore W, Mieles L.
    Liver Transpl; 2010 Mar 15; 16(3):289-99. PubMed ID: 20209588
    [Abstract] [Full Text] [Related]

  • 7. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
    Sharr WW, Chan SC, Lo CM.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S10-7. PubMed ID: 24849822
    [Abstract] [Full Text] [Related]

  • 8. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM, Vachharajani N, Klintmalm GB, Jarnagin WR, Hemming AW, Doyle MB, Cavaness KM, Chapman WC, Nagorney DM.
    Ann Surg; 2016 Oct 27; 264(4):650-8. PubMed ID: 27433910
    [Abstract] [Full Text] [Related]

  • 9. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
    Degroote H, Piñero F, Costentin C, Notarpaolo A, Boin IF, Boudjema K, Baccaro C, Chagas AL, Bachellier P, Ettorre GM, Poniachik J, Muscari F, Di Benedetto F, Duque SH, Salame E, Cillo U, Gadano A, Vanlemmens C, Fagiuoli S, Rubinstein F, Burra P, Cherqui D, Silva M, Van Vlierberghe H, Duvoux C, French-Italian-Belgium and Latin American collaborative group for HCC and liver transplantation.
    JHEP Rep; 2021 Oct 27; 3(5):100331. PubMed ID: 34485882
    [Abstract] [Full Text] [Related]

  • 10. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
    Agopian VG, Morshedi MM, McWilliams J, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Hiatt JR, Busuttil RW.
    Ann Surg; 2015 Sep 27; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
    [Abstract] [Full Text] [Related]

  • 11. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
    Tuci F, Vitale A, D'Amico F, Gringeri E, Neri D, Zanus G, Bassi D, Polacco M, Boetto R, Lodo E, Germani G, Burra P, Angeli P, Cillo U.
    Transplant Proc; 2014 Sep 27; 46(7):2287-9. PubMed ID: 25242770
    [Abstract] [Full Text] [Related]

  • 12. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
    Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW.
    Ann Surg; 2017 Sep 27; 266(3):525-535. PubMed ID: 28654545
    [Abstract] [Full Text] [Related]

  • 13. Favorable Long-term Outcome in Patients Submitted to Liver Transplantation After Downstaging of Hepatocellular Carcinoma According to a Brazilian Selection Protocol.
    Massarollo PC, Coppini AZ, Salzedas-Netto AA, Coelho FF, Minami T, Gonzalez AM.
    Transplant Proc; 2016 Sep 27; 48(7):2338-2340. PubMed ID: 27742292
    [Abstract] [Full Text] [Related]

  • 14. Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Murali AR, Romero-Marrero C, Miller C, Aucejo F, Levitin A, Gill A, McLennan G, Karuppasamy K, Zein NN, Lopez R, Menon KV.
    Transplantation; 2016 Nov 27; 100(11):2391-2397. PubMed ID: 27780187
    [Abstract] [Full Text] [Related]

  • 15. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
    Vutien P, Dodge J, Bambha KM, Nordstrom EM, Gralla J, Campbell K, Levek C, Nydam T, Fix O, Ioannou G, Biggins SW.
    Liver Transpl; 2019 Apr 27; 25(4):559-570. PubMed ID: 30706653
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.
    Abdelfattah MR, Elsiesy H, Al-Manea H, Broering DC.
    Eur J Gastroenterol Hepatol; 2018 Apr 27; 30(4):398-403. PubMed ID: 29280920
    [Abstract] [Full Text] [Related]

  • 17. Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.
    Gordon-Weeks AN, Snaith A, Petrinic T, Friend PJ, Burls A, Silva MA.
    Br J Surg; 2011 Sep 27; 98(9):1201-8. PubMed ID: 21618496
    [Abstract] [Full Text] [Related]

  • 18. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.
    Parikh ND, Waljee AK, Singal AG.
    Liver Transpl; 2015 Sep 27; 21(9):1142-52. PubMed ID: 25981135
    [Abstract] [Full Text] [Related]

  • 19. Benefit of downsizing hepatocellular carcinoma in a liver transplant population.
    Jang JW, You CR, Kim CW, Bae SH, Yoon SK, Yoo YK, Kim DG, Choi JY.
    Aliment Pharmacol Ther; 2010 Feb 01; 31(3):415-23. PubMed ID: 19821808
    [Abstract] [Full Text] [Related]

  • 20. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L, Heimbach JK, Zaiem F, Almasri J, Prokop LJ, Wang Z, Murad MH, Mohammed K.
    Hepatology; 2018 Jan 01; 67(1):381-400. PubMed ID: 28859222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.